Related Experiment Video
Updated: Jun 20, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li1,2, Fengshuo Liu3,4,5,6,7, Qingjin Cai1,2
1Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Abstract:
The progression of malignant tumors leads to the development of secondary tumors in various organs, including bones, the brain, liver, and lungs. This metastatic process severely impacts the prognosis of patients, significantly affecting their quality of life and survival rates. Research efforts have consistently focused on the intricate mechanisms underlying this process and the corresponding clinical management strategies. Consequently, a comprehensive understanding of the biological foundations of tumor metastasis, identification of pivotal signaling pathways, and systematic evaluation of existing and emerging therapeutic strategies are paramount to enhancing the overall diagnostic and treatment capabilities for metastatic tumors. However, current research is primarily focused on metastasis within specific cancer types, leaving significant gaps in our understanding of the complex metastatic cascade, organ-specific tropism mechanisms, and the development of targeted treatments. In this study, we examine the sequential processes of tumor metastasis, elucidate the underlying mechanisms driving organ-tropic metastasis, and systematically analyze therapeutic strategies for metastatic tumors, including those tailored to specific organ involvement. Subsequently, we synthesize the most recent advances in emerging therapeutic technologies for tumor metastasis and analyze the challenges and opportunities encountered in clinical research pertaining to bone metastasis. Our objective is to offer insights that can inform future research and clinical practice in this crucial field.
Insights
Tumor metastasis causes secondary tumors, impacting patient survival. This study examines metastasis mechanisms and therapeutic strategies, focusing on organ tropism and emerging treatments for better patient outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Malignant tumor progression often results in secondary tumors in organs like bone, brain, liver, and lungs.
- Tumor metastasis significantly worsens patient prognosis, quality of life, and survival rates.
- Current research often focuses on specific cancer types, leaving gaps in understanding the metastatic cascade and organ tropism.
Purpose of the Study:
- To examine the sequential processes of tumor metastasis.
- To elucidate mechanisms driving organ-tropic metastasis.
- To systematically analyze therapeutic strategies for metastatic tumors, including organ-specific treatments and emerging technologies.
Main Methods:
- Review and synthesis of existing literature on tumor metastasis.
- Analysis of biological mechanisms underlying organ-specific metastasis.
- Evaluation of current and emerging therapeutic strategies for metastatic cancers.
- Examination of challenges and opportunities in clinical research for bone metastasis.
Main Results:
- Detailed examination of the sequential steps in tumor metastasis.
- Elucidation of key mechanisms responsible for organ-specific metastasis (tropism).
- Systematic analysis of therapeutic interventions, including novel approaches for metastatic tumors.
- Identification of challenges and future directions in bone metastasis research.
Conclusions:
- A comprehensive understanding of metastasis mechanisms is crucial for improving patient outcomes.
- Targeted therapies and emerging technologies hold promise for treating metastatic disease.
- Further research, particularly on organ tropism and bone metastasis, is needed to advance clinical practice.
Related Concept Videos
Cancer
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

